Induction of complete remission of acute myeloid leukaemia by pegylated interferon-α-2a in a patient with transformed primary myelofibrosis

被引：25

作者：

Berneman, Zwi N. ^{[1
,2
]}

Anguille, Sebastien ^{[1
,2
]}

Van Marck, Veerle ^{[3
]}

Schroyens, Wilfried A. ^{[1
,2
]}

Van Tendeloo, Viggo F. ^{[2
]}

机构：

[1] Univ Antwerp Hosp, Div Haematol, Edegem, Belgium

[2] Univ Antwerp, Vaccine & Infect Dis Inst, B-2020 Antwerp, Belgium

[3] Univ Antwerp Hosp, Div Pathol, Edegem, Belgium

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2010年 / 149卷 / 01期

关键词：

interferon; acute leukaemia; myelofibrosis; leukaemia therapy; CELLS IN-VITRO; EXPERIENCE; GENE;

D O I：

10.1111/j.1365-2141.2009.08029.x

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：152 / 155

页数：4

共 10 条

[1]

Continuous delivery of human type I interferons (α/β) has significant activity against acute myeloid leukemia cells in vitro and in a xenograft model [J].

Benjamin, Reuben ;

Khwaja, Asim ;

Singh, Nalini ;

McIntosh, Jenny ;

Meager, Anthony ;

Wadhwa, Meenu ;

Streck, Christian ;

Ng, Catherine ;

Davidoff, Andrew M. ;

Nathwani, Amit C. .

BLOOD, 2007, 109 (03) :1244-1247

[2]

Geng YP, 1995, CYTOKINES MOL THER, V1, P289

[3]

PEG-IFN-α-2a therapy in patients with myelofibrosis [J].

Ianotto, Jean-Christophe ;

Kiladjian, Jean-Jacques ;

Demory, Jean-Louis ;

Roy, Lydia ;

Boyer, Francoise ;

Rey, Jerome ;

Dupriez, Brigitte ;

Berthou, Christian ;

Abgrall, Jean-Francois .

BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (02) :223-225

[4]

Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera [J].

Kiladjian, Jean-Jacques ;

Cassinat, Bruno ;

Chevret, Sylvie ;

Turlure, Pascal ;

Cambier, Nathalie ;

Roussel, Murielle ;

Bellucci, Sylvia ;

Grandchamp, Bernard ;

Chomienne, Christine ;

Fenaux, Pierre .

BLOOD, 2008, 112 (08) :3065-3072

[5]

Peginterferon alfa-2a: A review of approved and investigational uses [J].

Matthews, SJ ;

McCoy, C .

CLINICAL THERAPEUTICS, 2004, 26 (07) :991-1025

[6]

Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases [J].

Mesa, RA ;

Li, CY ;

Kettering, RP ;

Schroeder, GS ;

Knudson, RA ;

Tefferi, A .

BLOOD, 2005, 105 (03) :973-977

[7]

The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia [J].

Ogawa, H ;

Tamaki, H ;

Ikegame, K ;

Soma, T ;

Kawakami, M ;

Tsuboi, A ;

Kim, EH ;

Hosen, N ;

Murakami, M ;

Fujioka, T ;

Masuda, T ;

Taniguchi, Y ;

Nishida, S ;

Oji, Y ;

Oka, Y ;

Sugiyama, H .

BLOOD, 2003, 101 (05) :1698-1704

[8]

Mechanisms of type-I- and type-II-interferon-mediated signalling [J].

Platanias, LC .

NATURE REVIEWS IMMUNOLOGY, 2005, 5 (05) :375-386

[9]

ROHATINER AZS, 1983, CANCER CHEMOTH PHARM, V11, P56

[10]

Antitumor effect of interferon-α on U937 human acute leukemia cells in vitro and its molecular mechanism [J].

Zhang Chun ;

Cu Guohui ;

Chen Yan ;

Fan Ke .

JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2007, 27 (05) :513-515

← 1 →